(CLDX) Celldex Therapeutics - Performance -52.6% in 12m
Compare CLDX with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
29.35%
#19 in Group
Rel. Strength
11.00%
#7082 in Universe
Total Return 12m
-52.63%
#112 in Group
Total Return 5y
716.74%
#1 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -24.57%
(?) Percentile in Group
12m Total Return: CLDX (-52.6%) vs XBI (-12.3%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
UTHR NASDAQ United Therapeutics |
10.1% | 18% | 166% | 12.1 | 11 | 1.43 | 74.6% | 16.1% |
HLN NYSE Haleon |
14.3% | 31.2% | 47% | 24.4 | 20.2 | 1.79 | 69.1% | 13.6% |
AMGN NASDAQ Amgen |
-2.93% | -8.78% | 30.7% | 25.5 | 13.5 | 0.95 | 0.60% | 41% |
LONN SW Lonza |
9.55% | 9.34% | 30.4% | 67.1 | 35.1 | 1.28 | 2.20% | -12.5% |
BIM PA Biomerieux |
0.78% | 17.8% | -2.14% | 32.5 | 25.2 | 1.52 | -38.5% | -25.1% |
KMDA NASDAQ Kamada |
21.4% | 25.3% | -4.13% | 26.6 | 23.9 | 0.96 | 32.5% | 3.93% |
NBIX NASDAQ Neurocrine Biosciences |
34.3% | -15.5% | 3.48% | 32.3 | 21.6 | 0.27 | 68.0% | 31.9% |
ERF PA Eurofins Scientific SE |
20.4% | -0.39% | 7.63% | 26.6 | 13.6 | 0.56 | -66.6% | -17.1% |
Performance Comparison: CLDX vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for CLDX
Total Return (including Dividends) | CLDX | XBI | S&P 500 |
---|---|---|---|
1 Month | 29.02% | 11.81% | 13.81% |
3 Months | -9.34% | -13.61% | -6.30% |
12 Months | -52.63% | -12.29% | 10.65% |
5 Years | 716.74% | -24.89% | 107.77% |
Trend Score (consistency of price movement) | CLDX | XBI | S&P 500 |
1 Month | 69.5% | 72.9% | 83% |
3 Months | -60.8% | -83% | -75.3% |
12 Months | -90.9% | -51.6% | 50.1% |
5 Years | 26.4% | -53.9% | 84.1% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #48 | 15.4% | 13.4% |
3 Month | #84 | 4.95% | -3.24% |
12 Month | #111 | -46.0% | -57.2% |
5 Years | #1 | 987% | 293% |
FAQs
Does CLDX Celldex Therapeutics outperforms the market?
No,
over the last 12 months CLDX made -52.63%, while its related Sector, the SPDR S&P Biotech (XBI) made -12.29%.
Over the last 3 months CLDX made -9.34%, while XBI made -13.61%.
Over the last 3 months CLDX made -9.34%, while XBI made -13.61%.
Performance Comparison CLDX vs Indeces and Sectors
CLDX vs. Indices CLDX is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | -6.93% | 15.2% | -20.6% | -63.3% |
US NASDAQ 100 | QQQ | -7.12% | 11.7% | -20.8% | -64.3% |
US Dow Jones Industrial 30 | DIA | -7.34% | 19.0% | -20.3% | -60.3% |
German DAX 40 | DAX | -6.91% | 14.1% | -46.9% | -78.3% |
Shanghai Shenzhen CSI 300 | CSI 300 | -9.11% | 17.2% | -21.4% | -60.0% |
Hongkong Hang Seng | HSI | -10.1% | 9.09% | -29.0% | -66.3% |
India NIFTY 50 | INDA | -2.01% | 24.2% | -21.1% | -52.4% |
Brasil Bovespa | EWZ | -7.98% | 11.8% | -29.3% | -44.3% |
CLDX vs. Sectors CLDX is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | -7.57% | 15.6% | -27.7% | -74.2% |
Consumer Discretionary | XLY | -7.31% | 14.8% | -19.6% | -66.9% |
Consumer Staples | XLP | -6.07% | 22.4% | -27.5% | -61.8% |
Energy | XLE | -6.75% | 22.3% | -14.0% | -43.2% |
Financial | XLF | -8.03% | 15.5% | -27.7% | -75.1% |
Health Care | XLV | -3.92% | 28.2% | -15.6% | -48.6% |
Industrial | XLI | -8.62% | 12.2% | -22.0% | -63.6% |
Materials | XLB | -6.73% | 15.5% | -15.7% | -47.4% |
Real Estate | XLRE | -5.61% | 17.5% | -21.4% | -68.1% |
Technology | XLK | -8.01% | 7.80% | -17.7% | -59.7% |
Utilities | XLU | -6.98% | 19.4% | -28.3% | -70.1% |
Aerospace & Defense | XAR | -8.91% | 7.86% | -32.1% | -80.0% |
Biotech | XBI | -0.34% | 17.2% | -0.47% | -40.3% |
Homebuilder | XHB | -7.40% | 17.5% | -7.42% | -45.1% |
Retail | XRT | -8.83% | 14.4% | -16.4% | -51.2% |